1. Home
  2. XTNT vs NEPH Comparison

XTNT vs NEPH Comparison

Compare XTNT & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

HOLD

Current Price

$0.32

Market Cap

47.9M

Sector

Health Care

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.49

Market Cap

49.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XTNT
NEPH
Founded
N/A
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.9M
49.4M
IPO Year
2009
2004

Fundamental Metrics

Financial Performance
Metric
XTNT
NEPH
Price
$0.32
$3.49
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
$1.03
★ $6.25
AVG Volume (30 Days)
★ 185.7K
34.0K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
125.00
★ 1000.00
EPS
N/A
★ 0.12
Revenue
★ $53,337,000.00
$18,789,000.00
Revenue This Year
N/A
$17.81
Revenue Next Year
$10.85
$15.90
P/E Ratio
★ N/A
$28.88
Revenue Growth
N/A
★ 32.67
52 Week Low
$0.27
$2.66
52 Week High
$0.95
$6.42

Technical Indicators

Market Signals
Indicator
XTNT
NEPH
Relative Strength Index (RSI) 39.89 39.52
Support Level $0.32 $3.19
Resistance Level $0.49 $3.78
Average True Range (ATR) 0.02 0.31
MACD -0.00 -0.06
Stochastic Oscillator 0.00 34.57

Price Performance

Historical Comparison
XTNT
NEPH

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: